ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 40, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-09-08
DOI
10.1186/s13046-021-02088-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation
- (2020) Tao Liu et al. NUCLEIC ACIDS RESEARCH
- RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner
- (2020) Xingya Guo et al. Molecular Cancer
- ALKBH5 promotes the proliferation of renal cell carcinoma by regulating AURKB expression in an m6A-dependent manner
- (2020) Xiaolei Zhang et al. Annals of Translational Medicine
- FTO-Dependent N6-Methyladenosine Modifications Inhibit Ovarian Cancer Stem Cell Self-Renewal by Blocking cAMP Signaling
- (2020) Hao Huang et al. CANCER RESEARCH
- ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1
- (2020) Yunhao Chen et al. Molecular Cancer
- ALKBH5 regulates anti–PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment
- (2020) Na Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting oncogene mRNA translation in B cell malignancies with eFT226, a potent and selective inhibitor of eIF4A1
- (2020) Peggy A Thompson et al. MOLECULAR CANCER THERAPEUTICS
- Adenylate Kinase 4 Modulates the Resistance of Breast Cancer Cells to Tamoxifen through an m6A-Based Epitranscriptomic Mechanism
- (2020) Xiaochuan Liu et al. MOLECULAR THERAPY
- S6K1 blockade overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancer
- (2020) Hua Shen et al. ONCOGENE
- ALKBH5 inhibited cell proliferation and sensitized bladder cancer cells to cisplatin by m6A-CK2α mediated glycolysis
- (2020) Hao Yu et al. Molecular Therapy-Nucleic Acids
- N6-methyladenosine-modified CircRNA-SORE sustains sorafenib resistance in hepatocellular carcinoma by regulating β-catenin signaling
- (2020) Junjie Xu et al. Molecular Cancer
- The m6A RNA Demethylase ALKBH5 Promotes Radioresistance and Invasion Capability of Glioma Stem Cells
- (2020) Aline Kowalski-Chauvel et al. Cancers
- m6A methylation controls pluripotency of porcine induced pluripotent stem cells by targeting SOCS3/JAK2/STAT3 pathway in a YTHDF1/YTHDF2-orchestrated manner
- (2019) Ruifan Wu et al. Cell Death & Disease
- Ovarian Cancer: An Integrated Review
- (2019) Christine Stewart et al. Seminars in Oncology Nursing
- N6-methylation of adenosine (m6A) of FZD10 mRNA contributes to PARP inhibitor resistance
- (2019) Takeshi Fukumoto et al. CANCER RESEARCH
- ALKBH5 inhibited autophagy of epithelial ovarian cancer through miR-7 and BCL-2
- (2019) Hongtao Zhu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Re: Loss of Nuclear Functions of HOXA10 is Associated with Testicular Cancer Proliferation
- (2019) Jerome P. Richie JOURNAL OF UROLOGY
- Where, When, and How: Context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers
- (2019) Hailing Shi et al. MOLECULAR CELL
- Regulation of Gene Expression by N-methyladenosine in Cancer
- (2019) Jun Liu et al. TRENDS IN CELL BIOLOGY
- In vivo modelling of chemo-resistant neuroblastoma provides new insights into chemo-refractory disease and metastasis.
- (2019) Orli Yogev et al. CANCER RESEARCH
- NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019
- (2019) Deborah K. Armstrong et al. Journal of the National Comprehensive Cancer Network
- Upregulated LINC00565 Accelerates Ovarian Cancer Progression By Targeting GAS6
- (2019) Mi Gong et al. OncoTargets and Therapy
- m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis
- (2019) Dan Jin et al. Journal of Hematology & Oncology
- Tumor-suppressor role of miR-139-5p in endometrial cancer
- (2018) JinHui Liu et al. Cancer Cell International
- MIR142 loss-of-function mutations derepress ASH1L to increase HOXA gene expression and promote leukemogenesis
- (2018) Maria C. Trissal et al. CANCER RESEARCH
- MicroRNA‑665 suppresses the growth and migration of ovarian cancer cells by targeting HOXA10
- (2018) Jinhui Liu et al. Molecular Medicine Reports
- METTL3 promotes ovarian carcinoma growth and invasion through the regulation of AXL translation and epithelial to mesenchymal transition
- (2018) Wenfeng Hua et al. GYNECOLOGIC ONCOLOGY
- IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner
- (2018) Simon Müller et al. NUCLEIC ACIDS RESEARCH
- Human m6A writers: Two subunits, 2 roles
- (2017) Xiang Wang et al. RNA Biology
- Multiple facets of histone variant H2AX: a DNA double-strand-break marker with several biological functions
- (2015) Valentina Turinetto et al. NUCLEIC ACIDS RESEARCH
- Targeting JAK kinase in solid tumors: emerging opportunities and challenges
- (2015) M Buchert et al. ONCOGENE
- MiR-135a functions as a tumor suppressor in epithelial ovarian cancer and regulates HOXA10 expression
- (2014) Weiwei Tang et al. CELLULAR SIGNALLING
- N6-methyladenosine-dependent regulation of messenger RNA stability
- (2013) Xiao Wang et al. NATURE
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation